Results 1 to 10 of about 323 (107)

COMPARE THE EFFECTIVENESS OF NEBIVOLOL AND SOTALOL IN PATIENTS WITH HYPERTENSIVE DISEASE AND VENTRICULAR ARRHYTHMIAS [PDF]

open access: yesЕвразийский Кардиологический Журнал, 2016
Aim. Compare the effectiveness of nebivolol and sotalol in patients with hypertensive disease (HD) and ventricular arrhythmias (VA) taking into account its effect on regulatory adaptive status (RAS). Materials and methods.
I. Z. Shubitidze   +2 more
doaj   +3 more sources

Роль вегетативной нервной системы в стресс-индуцированном повреждении сердца [PDF]

open access: yes, 2021
 Aim. To identify the role of the autonomic nervous system in stress cardiomyopathy in an experimental model of Takotsubo syndrome.Materials and methods. The study was carried out on 120 female Wistar rats.
A. V. Krylatov   +17 more
core   +2 more sources

Nebivolol i dislipidemiya u bol'nykh sakharnym diabetom 2 tipa

open access: yesСахарный диабет, 2001
Цель. Оценка гипотензивных и метаболических последствий применения небиволола с NO-модулирующими свойствами у больных СД 2 типа. Материалы и методы. В рандомизированное проспективное исследование включено 35 больных СД 2 типа с мягкой артериальной не ...
Ivan Ivanovich Dedov   +3 more
doaj   +1 more source

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE

open access: yesРациональная фармакотерапия в кардиологии, 2015
Review is devoted to the role of modern beta-blocker nebivolol in the treatment of stable ischemic heart disease (IHD). The mode of nebivolol anti-ischemic activity is considered, as well as its use particularities in IHD patients with different ...
V. P. Lupanov
doaj   +1 more source

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY

open access: yesРациональная фармакотерапия в кардиологии, 2015
There were presented results of clinical trials on β-adrenoblockers usage in patients with chronic heart failure (CHF) as well as data of own study on nebivolol efficacy and tolerability in 113 patients with ischemic heart disease, complicated with CHF ...
M. L. Maximov
doaj   +1 more source

THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION

open access: yesРациональная фармакотерапия в кардиологии, 2015
Aim. To study the effects of nebivolol on bone mineral density (BMD) in postmenopausal women with mild hypertension (HT) and osteopenia.Material and methods.
I. L. Tepoyan   +6 more
doaj   +1 more source

Effect of antihypertensive drugs on specific markers of inflammation and disorders of carbohydrate metabolism in metabolic syndrome

open access: yesМедицинский совет, 2014
The potential of certain drugs to affect specific markers of progression of hypertension should be taken into account in the rational pharmacotherapy of arterial hypertension (AH) in patients with metabolic syndrome (MS).
TE Morozova   +2 more
doaj   +1 more source

Кардиопротекторные средства с биароматической структурой. Часть 6. Бета-блокаторы [PDF]

open access: yes, 2023
β-Blockers are one of the oldest classes of cardioprotectors used in the treatment of cardiovascular diseases. They reduce the heart rate, have a hypotensive effect, inhibit myocardial contractility and have antiarrhythmic properties.
G. V. Mokrov, Г. В. Мокров
core   +4 more sources

NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS

open access: yesРациональная фармакотерапия в кардиологии, 2015
Aim. To evaluate antianginal and antiischemic efficiency of nebivolol in patients with stable angina pectoris.Material and methods. 100 patients with ischemic heart disease showing stable exertional angina pectoris and having no contraindications to beta-
Y. V. Gavrilov   +2 more
doaj   +1 more source

EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To evaluate a short-term efficacy and safety of nebivolol and carvedilol in hypertensive patients of different ages in acute pharmacological test (APT).Material and methods.
O. V. Fedorishina   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy